ArticleMolecular and cellular pediatrics2026
Sepsis profile among preterm infants with enterostomy and fecal transfer: a multicenter retrospective cohort study.
Article in Molecular and cellular pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVery low birth weight infants (VLBWI, < 1500 g) with abdominal complications often require enterostomy, interrupting physiological intestinal passage. Mucous fistula refeeding (MFR; fecal transfer) aims to restore intestinal continuity and to improve nutrient absorption, yet concerns about infection risk persist. In this multicenter retrospective study, we evaluated the association between MFR and clinical risk profiles in VLBWI with enterostomy until stoma reversal. VLBWI with enterostomy were treated between 2009 and 2022 in five centers of the German Neonatal Network (GNN). Data of infants were grouped by local refeeding practice (MFR vs. no MFR). Logistic regression analyses assessed infections, cholestasis, and growth outcomes, adjusted for gestational age, birth weight, central line use, probiotic use, and antibiotic exposure.
resultsOf 60 infants, 26 received MFR and 34 did not. MFR infants showed lower rates of blood-culture–proven sepsis (11.5% vs. 36.4%, p = 0.03) and clinical sepsis (50.0% vs. 78.8%, p = 0.02). Recurrent infections occurred less often (46.2% vs. 75.8%, p = 0.02). Cholestasis and growth parameters were comparable. MFR remained independently associated with reduced odds of blood-culture–proven sepsis (OR 0.22 [95% CI 0.05–0.97], p = 0.046) and clinical sepsis (OR 0.10 [95% CI 0.02–0.58], p = 0.010).
conclusionsMFR in preterm infants with enterostomy was associated with lower sepsis rates supporting its potential as a safe intervention. Standardized refeeding protocols and prospective studies are warranted to confirm these benefits and to evaluate long-term outcomes after stoma reversal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.